PhillipEvanBarnetteJrMD

Pediatric Hematology & Oncology • Salt Lake City, UT

Associate Professor, Pediatrics, University of Utah School of Medicine

Join to view full profile

Dr. Barnette is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Barnette's full profile

Already have an account?

Office
100 Mario Capecchi Dr
Salt Lake City, UT 84113
Phone+1 801-662-4700

Education & Training

University of Utah HealthFellowship, Pediatric Hematology/Oncology, 2003
Oregon Health & Science University (OHSU Health)Residency, Pediatrics, 1997 - 2000
Oregon Health and Science University School of MedicineClass of 1997

Certifications & Licensure

UT State Medical License 2000 - 2026
OR State Medical License 1999 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Start of enrollment: 2001 Feb 01
Unknown status
Phase 3
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
Recruiting
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Start of enrollment: 2011 May 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

382 citations
Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Arend von Stackelberg, Franco Locatelli, Gerhard Zugmaier, Rupert Handgretinger, Tanya M. Trippett
Journal of Clinical Oncology. 2016-10-03
86 citations
Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study
Matthew F. Gorman, Lingyun Ji, Richard H. Ko, Phillip Barnette, Bruce Bostrom
Pediatric Blood & Cancer. 2010-09-01
7 citations
Incidence, risk factors, and pathogenesis of second malignancies in patients with non-Hodgkin lymphoma
Jonathan D. Tward, Martha Glenn, Michael A. Pulsipher, Phillip Barnette, David K. Gaffney
Leukemia & Lymphoma. 2007-08-01